Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04-03)

被引：0
作者：
Wen, P. Y.
Puduvalli, V.
Kuhn, J.
Reid, J.
Cloughesy, T.
Yung, W. A.
Chang, S. M.
Robbins, H. I.
McGovern, R.
Ames, M.
Prados, M. D.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] UT Southwestern, San Antonio, TX USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Univ Wisconsin, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2039
引用
收藏
页数：2
相关论文
共 50 条
[41]   A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas [J].
Vasilios Karavasilis ;
Vassiliki Kotoula ;
George Pentheroudakis ;
Despina Televantou ;
Sofia Lambaki ;
Sofia Chrisafi ;
Mattheos Bobos ;
George Fountzilas .
Journal of Neurology, 2013, 260 :1469-1480
[42]   PHASE I STUDY OF VORINOSTAT COMBINED WITH ISOTRETINOIN AND CARBOPLATIN IN ADULTS WITH RECURRENT MALIGNANT GLIOMAS [J].
Puduvalli, Vinay K. ;
Penas-Prado, Marta ;
Gilbert, Mark R. ;
Groves, Morris D. ;
Hess, Kenneth R. ;
Levin, Victor A. ;
de Groot, John ;
Colman, Howard ;
Conrad, Charles A. ;
Loghin, Monica E. ;
Hunter, Kathy ;
Yung, W. K. .
NEURO-ONCOLOGY, 2010, 12 :69-69
[43]   Vorinostat (suberoylanilide hydroxamic acid) as salvage therapy in metastatic breast cancer (MBC): A California Cancer Consortium phase II study [J].
Luu, T. H. ;
Leong, L. ;
Morgan, R. ;
McNamara, M. ;
Lim, D. ;
Portnow, J. ;
Frankel, P. ;
Aparicio, A. ;
Chew, H. ;
Gandara, D. R. ;
Somlo, G. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[44]   Translational Phase I Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytarabine and Etoposide in Patients with Relapsed, Refractory, or High-Risk Acute Myeloid Leukemia [J].
Gojo, Ivana ;
Tan, Ming ;
Fang, Hong-Bin ;
Sadowska, Mariola ;
Lapidus, Rena ;
Baer, Maria R. ;
Carrier, France ;
Beumer, Jan H. ;
Anyang, Bean N. ;
Srivastava, Rakesh K. ;
Espinoza-Delgado, Igor ;
Ross, Douglas D. .
CLINICAL CANCER RESEARCH, 2013, 19 (07) :1838-1851
[45]   Phase I study of oral suberoylanilide hydroxamic acid (SAHA) in patients (pts) with advanced leukemias or myelodysplastic syndromes (MDS). [J].
Garcia-Manero, G ;
Canalli, AA ;
Wierda, W ;
Cortes, J ;
O'Brien, S ;
Cupo, A ;
Secrist, JP ;
Davis, J ;
Faderl, S ;
Giles, F ;
Chiao, JH ;
Richon, V ;
Issa, JP ;
Kantarjian, H .
BLOOD, 2003, 102 (11) :254B-254B
[46]   A phase I study of bortezomib (BTZ) and temozolomide (TMZ) in patients with advanced solid tumors [J].
Portnow, J. ;
Koehler, S. ;
Cristea, M. C. ;
Chow, W. A. ;
Chung, V. M. ;
Lim, D. ;
Morgan, R. ;
Shibata, S. ;
Frankel, P. H. ;
Synold, T. W. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[47]   Phase I/II study of imatinib mesylate (STI571) for patients with recurrent malignant gliomas (NABTC 99-08) [J].
Wen, PY ;
Yung, WKA ;
Lamborn, K ;
Peng, B ;
Dahia, P ;
Abrey, L ;
Raiser, J ;
Cloughesy, T ;
Fink, K ;
Gilbert, M ;
Chang, S ;
Junck, L ;
Schiff, D ;
Lieberman, F ;
Fine, H ;
Mehta, M ;
Robins, HI ;
DeAngelis, LM ;
Hess, K ;
Groves, M ;
Puduvalli, VK ;
Levin, V ;
Conrad, C ;
Kuhn, J ;
Maher, E ;
Hayes, M ;
Silberman, S ;
Letvak, L ;
Capdeville, R ;
Kaplan, R ;
Murgo, A ;
Stiles, C ;
Prados, MD .
NEURO-ONCOLOGY, 2004, 6 (04) :385-385
[48]   A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas [J].
Kumthekar, Priya ;
Grimm, Sean ;
Chandler, James ;
Mehta, Minesh ;
Marymont, Maryanne ;
Levy, Robert ;
Muro, Kenji ;
Helenowski, Irene ;
McCarthy, Katie ;
Fountas, Leanne ;
Raizer, Jeffrey .
JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (03) :589-594
[49]   A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas [J].
Priya Kumthekar ;
Sean Grimm ;
James Chandler ;
Minesh Mehta ;
Maryanne Marymont ;
Robert Levy ;
Kenji Muro ;
Irene Helenowski ;
Katie McCarthy ;
Leanne Fountas ;
Jeffrey Raizer .
Journal of Neuro-Oncology, 2017, 133 :589-594
[50]   Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas [J].
Eric T. Wong ;
Joshua Timmons ;
Amy Callahan ;
Lauren O’Loughlin ;
Bridget Giarusso ;
David C. Alsop .
BMC Cancer, 16
12345